Unique Pharma is a legally registered pharmaceutical manufacturing company specializing in the research, development, and ethical production of high-quality, compound steroid medicines. Our operations are governed by strict adherence to regulatory standards and are conducted in a state-of-the-art facility. As a recognized entity in pharmaceutical manufacturing, we emphasize our scientific expertise and authority by committing to rigorous GMP compliance (Good Manufacturing Practice) and exhaustive internal quality control protocols. This ensures every product meets the highest standards for purity and safety, reflecting our dedication to industry best practices and our reputation for trustworthiness derived from years of operational experience.

The information presented on this platform is provided solely for general informational and compliance purposes. Our specialized compound steroid products are formulated and intended for prescription-regulated use only and/or for specific, verified research and development applications. Unique Pharma explicitly states that this content is not medical advice, a diagnosis, or a substitute for professional consultation. All published product data is based on verified research, internal quality assurance findings, and official regulatory guidance (including specifications for sterile drug products). Readers must always consult a licensed healthcare professional for any medical concerns or before using our products; we strictly avoid therapeutic claims.

We are committed to responsible communication, user-data privacy, and robust data protection standards. For complete transparency, we invite licensed medical professionals, researchers, and regulatory bodies to contact Unique Pharma directly to obtain verified documentation, GMP certifications, and full regulatory details relating to our products and our commitment to ethical production.

Regulatory Transparency

Unique Pharma Ltd. is registered as an Outsourcing Facility. We maintain transparency regarding our inspectional history. You may review the 2014 Inspectional Observations here: [Inspection_Report_2014.pdf]. Please note that these observations are part of the routine inspection process.